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The myelin proteolipid protein gene was characterized in jimpy mice to identify the specific mutation that 
produces dysmyelination, oligodendrocyte cell death, and death of the animal by 30 days of age. Exon 5 
and flanking intron segments were isolated from jimpy proteolipid protein genomic clones and sequenced. 
A single nucleotide difference was noted between the normal and jimpy proteolipid protein genes: the con- 
version of an AG/GT to a GG/GT in the splice acceptor signal preceding exon 5, which apparently destroys 
the splice signal. Thus, exon 5 of the mouse myelin proteolipid protein gene is skipped during the processing 
of mRNA, producing a shortened proteolipid protein mRNA. 
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1. INTRODUCTION 
Myelin protein gene expression has recently 
become one of the most intensively studied de- 
velopmental systems in neurobiology [ 1,2]. This 
results in part from the overall abundance of the 
myelin membrane constituents within the nervous 
system, as well as their relatively simple composi- 
tion, e.g. two genes, the myelin basic protein gene 
and the myelin proteolipid protein (PLP) gene pro- 
duce 80’7’0 of the CNS myelin membrane protein 
[3,4]. In addition, the expression of the myelin 
genes is tightly developmentally regulated, with the 
major peak of expression in mice occurring be- 
tween 10 and 25 days after birth. Several dys- 
myelinating mouse mutants have been character- 
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ized, and the genetic defect in one of these, the 
shiverer mutant, has been identified as a deletion 
of exons 2-7 of the myelin basic protein gene [5]. 
The jimpy (jp) mouse carries a recessive X- 
linked dysmyelination mutation, which produces 
tremors beginning approx. 11 days after birth, 
followed by seizures and death by day 30 [6]. The 
myelin PLP gene is the putative site of this muta- 
tion. This conclusion was reached because (i) PLP 
is found exclusively in CNS myelin, and the 
dysmyelination in jp mice is restricted to CNS 
myelin; (ii) the PLP gene maps to the same region 
of the X chromosome as the jp locus [7,8]; and (iii) 
PLP mRNA in jp mice is smaller than PLP 
mRNAs from normal mice [g-12]. Nave et al. [l l] 
definitively demonstrated, by sequencing a jp PLP 
cDNA, that the difference in size resulted from an 
internal 74 base deletion. They proposed that the 
specific alteration of the PLP mRNA results from 
a splicing defect in the processing of the PLP 
mRNA. This proposal was further supported by 
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subsequent information on the human and mouse 
proteolipid protein genes, which demonstrated 
that the excised segment of the_& PLP mRNA cor- 
responds exactly to exon 5 of the PLP gene 
[ 13,141. The current studies were undertaken to 
identify the specific mutation within the PLP gene 
in jp mice that causes this splicing defect. 
2. MATERIALS AND METHODS 
2.1. Preparation and screening of jp genomic 
library 
A jp genomic DNA library was obtained from 
A.T. Campagnoni, UCLA. It was prepared from 
a partial Mb01 digest of genomic jp DNA, by liga- 
tion to BamHI-cut A Jl [ 151. Clones containing the 
jp PLP gene were isolated by screening the library 
with a PLP-specific cDNA, BAS1013 [16], which 
contains sequences encoding the 3 ’ -end of exon 2 
to the 5’-end of exon 7, encompassing most of the 
coding region of the PLP mRNA. 
2.2. Southern blot analyses 
The jp PLP genomic clones were further char- 
acterized by restriction mapping. The following 
probes were used to map these clones: BAS1013; 
pJD13A (a rat PLP cDNA containing the 3’-end 
of exon 4 to the 5’-end of exon 7) [9]; and p27 (a 
full-length rat cDNA) [17]. Probes were labeled 
with [32P]dATP or -dCTP by nick translation [18] 
or random priming [ 191. Clones were digested with 
restriction endonucleases and separated on 0.8% 
agarose gels. Southern blots were prepared, hy- 
bridized with probe overnight, washed and auto- 
radiographed as in [9]. 
2.3. Subcloning of a jp genomic clone 
Two DNA fragments containing exon 5 were 
prepared isolated by digesting a jp PLP genomic 
clone with PvuII and BamHI (a 1.1 kb fragment 
containing the 5 ‘-end of exon 5), or with PvuII 
and BglII (a 1.4 kb fragment containing the 3 ‘-end 
of exon 5). These fragments were isolated in 1% 
agarose gels, electroeluted, and subcloned into 
Ml 3mp18, which had been digested with HincII 
and BarnHI. Insert-containing clones were iden- 
tified, isolated, and sequenced by standard 
dideoxy techniques using 6 and 8% denaturing 
acrylamide gels [20]. 
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3. RESULTS AND DISCUSSION 
Approx. 7 different PLP-specific clones were 
identified and isolated from a jp genomic library. 
These clones were characterized by restriction 
analysis, and two clones appeared to encompass 
most of the jp PLP gene (fig.1). These clones had 
essentially identical restriction maps relative to the 
normal mouse PLP gene [ 141, except for truncated 
ends caused by the cloning. 
Two restriction fragments containing the ends of 
exon 5 were isolated from clones KKjp7 and 
KKjp9, and subcloned into Ml3 for sequencing. 
These fragments were selected because a jp PLP 
cDNA sequence indicated that the site of the jp 
PLP gene mutation was likely to be in the splice ac- 
ceptor segment of the mouse PLP exon 5 [11,14]. 
Thus, exon 5 was sequenced, and the sequence in- 
dicates that there is a single base alteration in the 
splice acceptor sequence of this exon (fig.2). The 
sequence of the normal intron sequence upstream 
from exon 5 is GCTGCTTTTATGTATCTTAGI 
GT [14], and the sequence of this region in the jp 
PLP gene is GCTGCTTTTATGTATCTTGG/GT. 
The underlined nucleotide appears to be the only 
nucleotide difference between these two PLP genes 
around exon 5. This alteration of an AG/GT to a 
GG/GT apparently destroys this splice signal and 
eliminates this exon from the mature PLP mRNA 
in jp mice. The consensus ignal for a splice accep- 
tor signal is (Py),NCAG/G, and the underlined 
AG are the only nucleotides that are invariant in all 
splice acceptor sequences identified to date [21]. 
Thus, a mutation producing an AG to GG conver- 
sion of the splice acceptor sequence would be ex- 
pected to destroy the splice signal. 
These data are consistent with a recent report by 
Nave et al. ([22]; personal communication), who 
compared their data on the jp mouse PLP exon 5 
with the human PLP exon 5. It is possible in the 
current study to compare more of the intron se- 
quence, because the jp PLP gene sequence is 
directly compared to the normal mouse PLP gene, 
rather than the human gene. With this com- 
parison, it is possible to establish that there is no 
other sequence difference in 160 nucleotides 
upstream or downstream of the mouse PLP exon 
5. Thus, this mutation appears to be a single 
nucleotide alteration in the mouse PLP gene. 
PLP mRNA levels in 20 day jp mice are 5-10% 
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Fig. 1. Restriction map of the myelin PLP gene. Two isolated jimpy PLP genomic clones are shown in relationship to 
the normal PLP gene. Restriction enzymes utilized: HindHI, H; BarnHI, B; EcoRI, R; BglII, Bg; PvuII, P; KpnI, K. 
that of normal as measured by in vitro translation 
and by dot-blot analysis [9,23]. The fact that these 
levels are so low is important because at present, 
there is no clear correlation between these low 
levels of jp PLP mRNA and the specific mutation 
within the PLP gene in jp mice. The low levels 
presumably arise either from increased turnover of 
the PLP mRNA or from decreased transcription of 
the PLP gene in jp mice. Presently, it is not clear 
whether a 74-nucleotide deletion in the protein 
coding segment of a 3200-nucleotide mRNA would 
alter mRNA stability, but clearly this must be 
tested. The other possibility, i.e. that PLP gene 
transcription is reduced in jp mice, may in fact oc- 
cur because of specific aspects of this splicing 
defect. This splicing defect deletes an exon con- 
taining 74 nucleotides, which produces 
frameshift in the protein coding region. The 
a 
jp 
catgcctcta gccttatgaa gtttactctg 
PLP mRNA would be translated into a protein 
containing the first 206 amino acids of PLP and 
then 34 amino acids unrelated to PLP. By Sr 
nuclease mapping, mRNAs for both PLP and 
DM20 (an alternatively spliced PLP gene product 
[14,24]) are found in jp mice [10,12], so 
presumably low levels of both PLP and DM20 pro- 
teins containing the altered C-terminus can be syn- 
thesized in these animals. The possibility exists that 
the production of defective PLP and DM20 pro- 
tein could feedback and reduce the transcription of 
the gene. 
Such a possibility is somewhat supported by 
studies on the early expression of PLP mRNA in 
jp mice. PLP mRNA levels in young jp animals ap- 
pear to be near normal levels [9]. Jimpy mice at 3 
and 7 days of age have 89 and 49% of the PLP 
mRNA of age-matched controls, respectively, and 
Gly Val Leu Pro Trp 
gctgctttta tgtatcttgg GT GTT CTC CCA TGG 
a 
Asn Ala Phe Pro Gly Lys Val Cys Gly Ser Asn Leu Leu Ser Ile Cys Lys Thr 
AAT GCT TTC CCT GGC AAG GTT TGT GGC TCC AAC CTT CTG TCC ATC TGC AAA ACA 
Ala Glu 
GCT GAG gtaagtgaat gagaagagtg ctttttaaaa aatagattgg ctagacatgg 
Fig.2. Sequence of exon 5 and flanking intron segments of the myelin PLP gene in jp mice. The single nucleotide 
difference between exon 5 of jp mice and normal mice is underlined, and the correct base for the normal PLP gene 
is identified below. 
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it drops as the animals age, to 12.5% of normal 
lo-day animals and 5-6% of normal 20-25day 
animals. These data would suggest that PLP 
mRNA levels in very young jp mice are close to 
normal levels, but that at the age when normal 
animals begin to increase significantly their level of 
PLP mRNA (between 10 and 25 days), the jp mice 
maintain their same low levels of PLP mRNA ex- 
pression. Thus, the early transcription rate of the 
PLP gene may be close to normal, and it is possible 
that when defective PLP and DM20 proteins are 
translated from these mRNAs in the young 
animals, their presence triggers a cellular response 
to prevent the normal increase in PLP gene 
transcription. 
In summary, the current study identifies the 
specific nucleotide alteration within the PLP gene 
that produces the jp mRNA defect. This mutation 
causes a splicing defect that eliminates exon 5 from 
the PLP mRNA, and produces aberrant PLP and 
DM20 protein. This single base mutation causes 
oligodendrocyte cell death, astrocyte hypertrophy 
and essentially the total absence of CNS myelin. 
Neither jp mice nor jpmsd mice [25], which are 
allelic to jp and presumably also have an altered 
PLP gene, survive past 30 days of age. Thus, it ap- 
pears that alterations in the expression of the 
myelin PLP gene are lethal at a very early age. In 
comparison, in other mouse dysmyelination 
mutants, alterations in the myelin basic protein 
gene and presumably other myelin protein genes 
grossly reduce the amount of myelin produced; 
these animals also have tremors and seizures 
throughout their lifetime. Nevertheless, these 
mutants have less severe clinical problems, as com- 
pared to the jp mutant. For example, shiverer 
mice, which carry a deletion of the myelin basic 
protein gene [5]; myelin-deficient mice, which 
carry a duplication of the myelin basic protein 
gene, and produce very low levels of myelin basic 
protein [26]; and quaking mice, which carry an 
undefined genetic defect, yet are quite deficient in 
myelin production, all have much longer lifespans, 
somewhat more myelin, and are generally healthier 
than jp mice. In quaking mice, the dysmyelination 
has no effect on lifespan, and adult females are 
even fertile. Why an inappropriately spliced PLP 
mRNA in jp mice should produce early astrocyte 
changes, oligodendrocyte cell death, and the very 
premature death of the animal is an important 
420 
question that is currently under active in- 
vestigation. 
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